Keyphrases
High Risk
100%
Vascular Events
100%
Ramipril
100%
Telmisartan
100%
Diabetes
37%
Confidence Interval
25%
Relative Risk
25%
Combination Therapy
25%
Angiotensin-converting Enzyme Inhibitor (ACEi)
25%
Syncope
25%
Angiotensin Receptor Blockers
25%
Therapy Groups
25%
Angioedema
25%
Vascular Disease Risk
25%
Adverse Events
12%
Composite Outcome
12%
Myocardial Infarction
12%
Low Dose Rate
12%
Mean Blood Pressure
12%
Heart Failure
12%
Cough
12%
Renal Disease
12%
Heart Failure Hospitalization
12%
Drug Combination Therapy
12%
Vascular Disease
12%
Pharmacology, Toxicology and Pharmaceutical Science
Ramipril
100%
Telmisartan
100%
Combination Therapy
37%
Vascular Disease
37%
Dipeptidyl Carboxypeptidase Inhibitor
25%
Congestive Heart Failure
25%
Angiotensin Receptor Antagonist
25%
Angioneurotic Edema
25%
Faintness
25%
Adverse Event
12%
Heart Infarction
12%
Antihypertensive Agent
12%
Coughing
12%
Cerebrovascular Accident
12%
Combination Drug
12%